Select all correct descriptions of Alzheimer's disease.Multiple select question.Autoimmune attacks cause myelin lossAccumulation of amyloid plaquesAppearance of neurofribillary tanglesReduction of brain acetylcholine levelsLoss of dopamine-producing neurons in basal ganglia of the brain

Select the correct statement(s).Group of answer choicesDementia is common in the elderly and is considered part of normal ageing.Prominent brain areas affected the most by Alzheimer’s disease are the prefrontal cortex, amygdala, and hippocampus.Alzheimer’s disease is associated with intracellular accumulation of amyloid beta plaques and extracellular deposition of abnormal tau proteins.Alzheimer’s disease is associated with a significant reduction of cholinergic neurons in the brain, which explains why administration of acetylcholinesterase inhibitors appears to be advantageous in the management of this condition.

How does the presence of neurofibrilliary (tau) tangles contribute to the pathogenesis of Alzheimer’s disease?Question 48Select one:a.They instigate sclerosis and plaque formation.b.They trigger a strong inflammatory response.c.They lead to the build-up of large intercellular plaques.d.They cause the deposition of intercellular β-amyloid.e.They disrupt intraneuronal communication and transport.

Structural changes in the brain in Alzheimer's disease include which of the following:Group of answer choicesSignificant aluminium deposits in the frontal lobeHypertrophy of the hippocampusDeposition of amyloid plaques and neurofibrillary tanglesDegeneration of the basal ganglia

Assist me in rephrasing , tidying and reduce any unnecessary word count that may confuse the reader for my introductory paragraph ensuring coherent and a logical flow : Dementia represents one of the major health problems in elderly individuals, with progressive deterioration of cognition, daily activity functioning and behavior that together lead to disability. Among the myriad forms of dementia, Alzheimer's Disease (AD) emerges as the most prevalent, accounting for a significant proportion of dementia cases worldwide. AD is a progressive neurodegenerative disorder characterized by cognitive and memory deterioration, a variety of neuropsychiatric symptoms, and behavioral disturbances.AD not only robs individuals of their memories and abilities but also presents complex challenges for caregivers and healthcare providers alike. Approximately 40 million people over 65 years suffer from dementia, and 70% of them are affected by Alzheimer's disease (AD) that represents the most diffuse type of dementia. In the face of an aging global population, the prevalence of AD is expected to escalate, amplifying the urgency for effective interventions. According to the World Health Organization, it is estimated that there are currently around 50 million people worldwide with dementia, with Alzheimer's Disease accounting for 60-70% of these cases. The number of people affected is projected to double every 20 years, reaching 82 million by 2030 and 152 million by 2050. Despite advancements in pharmacological treatments, existing medications only offer modest symptomatic relief and fail to alter the underlying disease progression significantly. In contrast, non-pharmacological treatment (NPT) presents promising alternatives, is non-invasive, safe, and has few side effects encompassing cognitive, behavioral, psychosocial, physical, and environmental intervention aspects of the disease to enhance overall well-being and quality of life for individuals with AD and their caregivers. Therefore, this review essay strives to examine the non-pharmacological treatments for AD, shedding light on their efficacies, mechanisms of action, and implications for clinical practice and research in the future.

Early stages of Alzheimer's disease are often attributed to normal agingQuestion 10Select one:TrueFalse